Search research articles
Contact Us
Filters
Showing results (31-40 of 69) with videos related to
Page
of 7
Sort By:
Heart (British Cardiac Society)
|
March 8, 2013
Association between discharge heart rate and left ventricular adverse remodelling in ST segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention
Emer Joyce, Georgette E Hoogslag, Darryl P Leong, et al.
International Journal of Cardiology
|
August 15, 2006
64-multislice computed tomography in consecutive patients with suspected or proven coronary artery disease: initial single center experience
Carmine Musto, Padley Simon, Edward Nicol, et al.
Emerging Infectious Diseases
|
April 25, 2002
A waterborne outbreak of Escherichia coli O157:H7 infections and hemolytic uremic syndrome: implications for rural water systems
Sonja J Olsen, Gayle Miller, Thomas Breuer, et al.
International Journal of Cardiology
|
May 28, 2013
Heart rate is a prognostic risk factor for myocardial infarction: a post hoc analysis in the PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack) study population
Kim Fox, Marie-Germaine Bousser, Pierre Amarenco, et al.
European Journal of Preventive Cardiology
|
August 23, 2014
Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: Data from the contemporary CLARIFY registry
Roberto Ferrari, Ian Ford, Nicola Greenlaw, et al.
Journal of the American College of Cardiology
|
November 27, 2007
The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial
Jasper J Brugts, Eric Boersma, Michel Chonchol, et al.
European Heart Journal
|
February 25, 2006
Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk
Jaap W Deckers, Dick M Goedhart, Eric Boersma, et al.
Heart (British Cardiac Society)
|
December 1, 2006
Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study
Andrew Briggs, Borislava Mihaylova, Mark Sculpher, et al.
European Heart Journal
|
April 7, 2009
The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials
Jasper J Brugts, Toshiharu Ninomiya, Eric Boersma, et al.
The American Journal of Cardiology
|
January 17, 2012
Cardiovascular mortality and heart failure risk score for patients after ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention (Data from the Leiden MISSION! Infarct Registry)
M Louisa Antoni, Georgette E Hoogslag, Helèn Boden, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 69) with videos related to
Sort By:
Page
of 7
Heart (British Cardiac Society)
|
March 8, 2013
Association between discharge heart rate and left ventricular adverse remodelling in ST segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention
Emer Joyce, Georgette E Hoogslag, Darryl P Leong, et al.
International Journal of Cardiology
|
August 15, 2006
64-multislice computed tomography in consecutive patients with suspected or proven coronary artery disease: initial single center experience
Carmine Musto, Padley Simon, Edward Nicol, et al.
Emerging Infectious Diseases
|
April 25, 2002
A waterborne outbreak of Escherichia coli O157:H7 infections and hemolytic uremic syndrome: implications for rural water systems
Sonja J Olsen, Gayle Miller, Thomas Breuer, et al.
International Journal of Cardiology
|
May 28, 2013
Heart rate is a prognostic risk factor for myocardial infarction: a post hoc analysis in the PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack) study population
Kim Fox, Marie-Germaine Bousser, Pierre Amarenco, et al.
European Journal of Preventive Cardiology
|
August 23, 2014
Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: Data from the contemporary CLARIFY registry
Roberto Ferrari, Ian Ford, Nicola Greenlaw, et al.
Journal of the American College of Cardiology
|
November 27, 2007
The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial
Jasper J Brugts, Eric Boersma, Michel Chonchol, et al.
European Heart Journal
|
February 25, 2006
Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk
Jaap W Deckers, Dick M Goedhart, Eric Boersma, et al.
Heart (British Cardiac Society)
|
December 1, 2006
Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study
Andrew Briggs, Borislava Mihaylova, Mark Sculpher, et al.
European Heart Journal
|
April 7, 2009
The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials
Jasper J Brugts, Toshiharu Ninomiya, Eric Boersma, et al.
The American Journal of Cardiology
|
January 17, 2012
Cardiovascular mortality and heart failure risk score for patients after ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention (Data from the Leiden MISSION! Infarct Registry)
M Louisa Antoni, Georgette E Hoogslag, Helèn Boden, et al.
Page
of 7